ID   SATT_HUMAN              Reviewed;         532 AA.
AC   P43007; B7Z3C0; D6W5F0;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1995, sequence version 1.
DT   10-MAY-2017, entry version 159.
DE   RecName: Full=Neutral amino acid transporter A;
DE   AltName: Full=Alanine/serine/cysteine/threonine transporter 1;
DE            Short=ASCT-1;
DE   AltName: Full=SATT;
DE   AltName: Full=Solute carrier family 1 member 4;
GN   Name=SLC1A4; Synonyms=ASCT1, SATT;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain cortex;
RX   PubMed=8101838;
RA   Arriza J.L., Kavanaugh M.P., Fairman W.A., Wu Y.-N., Murdoch G.H.,
RA   North R.A., Amara S.G.;
RT   "Cloning and expression of a human neutral amino acid transporter with
RT   structural similarity to the glutamate transporter gene family.";
RL   J. Biol. Chem. 268:15329-15332(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Hippocampus;
RX   PubMed=8340364;
RA   Shafqat S., Tamarappoo B.K., Kilberg M.S., Puranam R.S.,
RA   McNamara J.O., Guadano-Ferraz A., Fremeau R.T. Jr.;
RT   "Cloning and expression of a novel Na(+)-dependent neutral amino acid
RT   transporter structurally related to mammalian Na+/glutamate
RT   cotransporters.";
RL   J. Biol. Chem. 268:15351-15355(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Placenta;
RX   PubMed=7896285; DOI=10.1006/geno.1994.1577;
RA   Hofmann K., Dueker M., Fink T., Lichter P., Stoffel W.;
RT   "Human neutral amino acid transporter ASCT1: structure of the gene
RT   (SLC1A4) and localization to chromosome 2p13-p15.";
RL   Genomics 24:20-26(1994).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Hippocampus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lymph, and PNS;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=17081065; DOI=10.1021/pr060363j;
RA   Chi A., Valencia J.C., Hu Z.-Z., Watabe H., Yamaguchi H.,
RA   Mangini N.J., Huang H., Canfield V.A., Cheng K.C., Yang F., Abe R.,
RA   Yamagishi S., Shabanowitz J., Hearing V.J., Wu C., Appella E.,
RA   Hunt D.F.;
RT   "Proteomic and bioinformatic characterization of the biogenesis and
RT   function of melanosomes.";
RL   J. Proteome Res. 5:3135-3144(2006).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-507, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-201 AND ASN-206.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19349973; DOI=10.1038/nbt.1532;
RA   Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,
RA   Schiess R., Aebersold R., Watts J.D.;
RT   "Mass-spectrometric identification and relative quantification of N-
RT   linked cell surface glycoproteins.";
RL   Nat. Biotechnol. 27:378-386(2009).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [16]
RP   INVOLVEMENT IN SPATCCM, AND VARIANT SPATCCM LYS-256.
RX   PubMed=25930971; DOI=10.1111/cge.12605;
RA   Srour M., Hamdan F.F., Gan-Or Z., Labuda D., Nassif C., Oskoui M.,
RA   Gana-Weisz M., Orr-Urtreger A., Rouleau G.A., Michaud J.L.;
RT   "A homozygous mutation in SLC1A4 in siblings with severe intellectual
RT   disability and microcephaly.";
RL   Clin. Genet. 88:E1-E4(2015).
RN   [17]
RP   INVOLVEMENT IN SPATCCM, AND VARIANT SPATCCM LYS-256.
RX   PubMed=26138499; DOI=10.1111/cge.12637;
RA   Heimer G., Marek-Yagel D., Eyal E., Barel O., Oz Levi D., Hoffmann C.,
RA   Ruzzo E.K., Ganelin-Cohen E., Lancet D., Pras E., Rechavi G.,
RA   Nissenkorn A., Anikster Y., Goldstein D.B., Ben Zeev B.;
RT   "SLC1A4 mutations cause a novel disorder of intellectual disability,
RT   progressive microcephaly, spasticity and thin corpus callosum.";
RL   Clin. Genet. 88:327-335(2015).
RN   [18]
RP   FUNCTION, INVOLVEMENT IN SPATCCM, VARIANTS SPATCCM LYS-256 AND
RP   TRP-457, AND CHARACTERIZATION OF VARIANTS SPATCCM LYS-256 AND TRP-457.
RX   PubMed=26041762; DOI=10.1136/jmedgenet-2015-103104;
RA   Damseh N., Simonin A., Jalas C., Picoraro J.A., Shaag A., Cho M.T.,
RA   Yaacov B., Neidich J., Al-Ashhab M., Juusola J., Bale S.,
RA   Telegrafi A., Retterer K., Pappas J.G., Moran E., Cappell J.,
RA   Anyane Yeboa K., Abu-Libdeh B., Hediger M.A., Chung W.K., Elpeleg O.,
RA   Edvardson S.;
RT   "Mutations in SLC1A4, encoding the brain serine transporter, are
RT   associated with developmental delay, microcephaly and
RT   hypomyelination.";
RL   J. Med. Genet. 52:541-547(2015).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Transporter for alanine, serine, cysteine, and
CC       threonine. Exhibits sodium dependence.
CC       {ECO:0000269|PubMed:26041762}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:17081065};
CC       Multi-pass membrane protein {ECO:0000269|PubMed:17081065}.
CC       Melanosome {ECO:0000269|PubMed:17081065}. Note=Identified by mass
CC       spectrometry in melanosome fractions from stage I to stage IV.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P43007-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P43007-2; Sequence=VSP_042880, VSP_042881;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed mostly in brain, muscle, and
CC       pancreas but detected in all tissues examined.
CC   -!- DISEASE: Spastic tetraplegia, thin corpus callosum, and
CC       progressive microcephaly (SPATCCM) [MIM:616657]: A
CC       neurodevelopmental disorder characterized by thin corpus callosum,
CC       severe progressive microcephaly, severe intellectual disability,
CC       seizures, spasticity, and global developmental delay. Most
CC       patients are unable to achieve independent walking or speech.
CC       {ECO:0000269|PubMed:25930971, ECO:0000269|PubMed:26041762,
CC       ECO:0000269|PubMed:26138499}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the dicarboxylate/amino acid:cation
CC       symporter (DAACS) (TC 2.A.23) family. SLC1A4 subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L14595; AAA02761.1; -; mRNA.
DR   EMBL; L19444; AAA19438.1; -; mRNA.
DR   EMBL; U05235; AAC51349.1; -; Genomic_DNA.
DR   EMBL; U05229; AAC51349.1; JOINED; Genomic_DNA.
DR   EMBL; U05230; AAC51349.1; JOINED; Genomic_DNA.
DR   EMBL; U05231; AAC51349.1; JOINED; Genomic_DNA.
DR   EMBL; U05232; AAC51349.1; JOINED; Genomic_DNA.
DR   EMBL; U05233; AAC51349.1; JOINED; Genomic_DNA.
DR   EMBL; U05234; AAC51349.1; JOINED; Genomic_DNA.
DR   EMBL; AK295687; BAH12156.1; -; mRNA.
DR   EMBL; AC007386; AAF03519.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAW99932.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAW99933.1; -; Genomic_DNA.
DR   EMBL; BC026216; AAH26216.1; -; mRNA.
DR   EMBL; BC072423; AAH72423.1; -; mRNA.
DR   CCDS; CCDS1879.1; -. [P43007-1]
DR   CCDS; CCDS54362.1; -. [P43007-2]
DR   PIR; I37188; I37188.
DR   PIR; I55389; I55389.
DR   RefSeq; NP_001180422.1; NM_001193493.1. [P43007-2]
DR   RefSeq; NP_003029.2; NM_003038.4. [P43007-1]
DR   UniGene; Hs.654352; -.
DR   ProteinModelPortal; P43007; -.
DR   BioGrid; 112400; 5.
DR   IntAct; P43007; 1.
DR   MINT; MINT-4656683; -.
DR   STRING; 9606.ENSP00000234256; -.
DR   DrugBank; DB00160; L-Alanine.
DR   TCDB; 2.A.23.3.1; the dicarboxylate/amino acid:cation (na(+) or h(+)) symporter (daacs) family.
DR   iPTMnet; P43007; -.
DR   PhosphoSitePlus; P43007; -.
DR   SwissPalm; P43007; -.
DR   BioMuta; SLC1A4; -.
DR   DMDM; 1173365; -.
DR   EPD; P43007; -.
DR   MaxQB; P43007; -.
DR   PaxDb; P43007; -.
DR   PeptideAtlas; P43007; -.
DR   PRIDE; P43007; -.
DR   DNASU; 6509; -.
DR   Ensembl; ENST00000234256; ENSP00000234256; ENSG00000115902. [P43007-1]
DR   Ensembl; ENST00000531327; ENSP00000431942; ENSG00000115902. [P43007-2]
DR   GeneID; 6509; -.
DR   KEGG; hsa:6509; -.
DR   UCSC; uc010ypz.3; human. [P43007-1]
DR   CTD; 6509; -.
DR   DisGeNET; 6509; -.
DR   GeneCards; SLC1A4; -.
DR   HGNC; HGNC:10942; SLC1A4.
DR   HPA; HPA034963; -.
DR   HPA; HPA034964; -.
DR   MalaCards; SLC1A4; -.
DR   MIM; 600229; gene.
DR   MIM; 616657; phenotype.
DR   neXtProt; NX_P43007; -.
DR   OpenTargets; ENSG00000115902; -.
DR   PharmGKB; PA35829; -.
DR   eggNOG; KOG3787; Eukaryota.
DR   eggNOG; COG1301; LUCA.
DR   GeneTree; ENSGT00760000119117; -.
DR   HOGENOM; HOG000208776; -.
DR   HOVERGEN; HBG000080; -.
DR   InParanoid; P43007; -.
DR   KO; K05615; -.
DR   OMA; CMAAVFI; -.
DR   OrthoDB; EOG091G0UCE; -.
DR   PhylomeDB; P43007; -.
DR   TreeFam; TF315206; -.
DR   Reactome; R-HSA-352230; Amino acid transport across the plasma membrane.
DR   ChiTaRS; SLC1A4; human.
DR   GeneWiki; SLC1A4; -.
DR   GenomeRNAi; 6509; -.
DR   PMAP-CutDB; P43007; -.
DR   PRO; PR:P43007; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000115902; -.
DR   CleanEx; HS_SLC1A4; -.
DR   Genevisible; P43007; HS.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0030425; C:dendrite; IEA:Ensembl.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; NAS:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IC:UniProtKB.
DR   GO; GO:0005882; C:intermediate filament; ISS:UniProtKB.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0015171; F:amino acid transmembrane transporter activity; TAS:Reactome.
DR   GO; GO:0005254; F:chloride channel activity; IDA:UniProtKB.
DR   GO; GO:0015180; F:L-alanine transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0015184; F:L-cystine transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0015186; F:L-glutamine transmembrane transporter activity; TAS:BHF-UCL.
DR   GO; GO:0034590; F:L-hydroxyproline transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0015193; F:L-proline transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0015194; F:L-serine transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0015195; F:L-threonine transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0015293; F:symporter activity; IEA:UniProtKB-KW.
DR   GO; GO:0006865; P:amino acid transport; TAS:Reactome.
DR   GO; GO:0050890; P:cognition; IMP:UniProtKB.
DR   GO; GO:0006868; P:glutamine transport; TAS:BHF-UCL.
DR   GO; GO:0034589; P:hydroxyproline transport; IDA:UniProtKB.
DR   GO; GO:0015808; P:L-alanine transport; IDA:UniProtKB.
DR   GO; GO:0015811; P:L-cystine transport; IDA:UniProtKB.
DR   GO; GO:0015825; P:L-serine transport; IDA:UniProtKB.
DR   GO; GO:0015824; P:proline transport; IDA:UniProtKB.
DR   GO; GO:0035249; P:synaptic transmission, glutamatergic; NAS:UniProtKB.
DR   GO; GO:0015826; P:threonine transport; IDA:UniProtKB.
DR   Gene3D; 1.10.3860.10; -; 1.
DR   InterPro; IPR001991; Na-dicarboxylate_symporter.
DR   InterPro; IPR018107; Na-dicarboxylate_symporter_CS.
DR   Pfam; PF00375; SDF; 1.
DR   PRINTS; PR00173; EDTRNSPORT.
DR   SUPFAM; SSF118215; SSF118215; 2.
DR   PROSITE; PS00713; NA_DICARBOXYL_SYMP_1; 1.
DR   PROSITE; PS00714; NA_DICARBOXYL_SYMP_2; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Complete proteome;
KW   Disease mutation; Epilepsy; Glycoprotein; Membrane;
KW   Mental retardation; Phosphoprotein; Polymorphism; Reference proteome;
KW   Symport; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    532       Neutral amino acid transporter A.
FT                                /FTId=PRO_0000202079.
FT   TOPO_DOM      1     41       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     42     62       Helical. {ECO:0000255}.
FT   TRANSMEM     88    108       Helical. {ECO:0000255}.
FT   TRANSMEM    119    139       Helical. {ECO:0000255}.
FT   TOPO_DOM    140    216       Extracellular. {ECO:0000255}.
FT   TRANSMEM    217    237       Helical. {ECO:0000255}.
FT   TRANSMEM    257    277       Helical. {ECO:0000255}.
FT   TRANSMEM    298    318       Helical. {ECO:0000255}.
FT   TRANSMEM    328    348       Helical. {ECO:0000255}.
FT   TRANSMEM    373    393       Helical. {ECO:0000255}.
FT   TRANSMEM    418    438       Helical. {ECO:0000255}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:22814378}.
FT   MOD_RES     507    507       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     527    527       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O35874}.
FT   MOD_RES     530    530       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O35874}.
FT   CARBOHYD    201    201       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19349973}.
FT   CARBOHYD    206    206       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19349973}.
FT   VAR_SEQ       1    220       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_042880.
FT   VAR_SEQ     267    345       WYVPVGIMFLVGSKIVEMKDIIVLVTSLGKYIFASILGHVI
FT                                HGGIVLPLIYFVFTRKNPFRFLLGLLAPFATAFATCSS ->
FT                                C (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_042881.
FT   VARIANT      37     37       G -> R (in dbSNP:rs1064512).
FT                                /FTId=VAR_011878.
FT   VARIANT     256    256       E -> K (in SPATCCM; does not affect
FT                                localization at the cell surface;
FT                                decreased uptake of L-serine and L-
FT                                alanine; Vmax is decreased by at least
FT                                50% for both substrates; 3-fold increase
FT                                of affinity for L-serine; 2-fold increase
FT                                of affinity for L-alanine;
FT                                dbSNP:rs201278558).
FT                                {ECO:0000269|PubMed:25930971,
FT                                ECO:0000269|PubMed:26041762,
FT                                ECO:0000269|PubMed:26138499}.
FT                                /FTId=VAR_075085.
FT   VARIANT     399    399       V -> I (in dbSNP:rs759458).
FT                                /FTId=VAR_011879.
FT   VARIANT     457    457       R -> W (in SPATCCM; does not affect
FT                                localization at the cell surface; loss of
FT                                uptake of L-serine and L-alanine;
FT                                dbSNP:rs761533681).
FT                                {ECO:0000269|PubMed:26041762}.
FT                                /FTId=VAR_075086.
FT   CONFLICT    117    117       A -> R (in Ref. 1; AAA02761).
FT                                {ECO:0000305}.
FT   CONFLICT    127    127       S -> T (in Ref. 2; AAA19438).
FT                                {ECO:0000305}.
SQ   SEQUENCE   532 AA;  55723 MW;  57925860042FCEB6 CRC64;
     MEKSNETNGY LDSAQAGPAA GPGAPGTAAG RARRCAGFLR RQALVLLTVS GVLAGAGLGA
     ALRGLSLSRT QVTYLAFPGE MLLRMLRMII LPLVVCSLVS GAASLDASCL GRLGGIAVAY
     FGLTTLSASA LAVALAFIIK PGSGAQTLQS SDLGLEDSGP PPVPKETVDS FLDLARNLFP
     SNLVVAAFRT YATDYKVVTQ NSSSGNVTHE KIPIGTEIEG MNILGLVLFA LVLGVALKKL
     GSEGEDLIRF FNSLNEATMV LVSWIMWYVP VGIMFLVGSK IVEMKDIIVL VTSLGKYIFA
     SILGHVIHGG IVLPLIYFVF TRKNPFRFLL GLLAPFATAF ATCSSSATLP SMMKCIEENN
     GVDKRISRFI LPIGATVNMD GAAIFQCVAA VFIAQLNNVE LNAGQIFTIL VTATASSVGA
     AGVPAGGVLT IAIILEAIGL PTHDLPLILA VDWIVDRTTT VVNVEGDALG AGILHHLNQK
     ATKKGEQELA EVKVEAIPNC KSEEETSPLV THQNPAGPVA SAPELESKES VL
//
